Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Learned Consumer Protection Lesson From 2004 Flu Scare

This article was originally published in The Tan Sheet

Executive Summary

The roster of teams FDA assembled to respond to the 2009-N1H1 flu outbreak includes a consumer protection group to identify potentially dangerous products marketed as cures for the virus

You may also be interested in...



China’s New SFDA Chief Has Public Health Background, International Ties

Yin Li becomes director of China’s State FDA, taking the reins from Shao Mingli, who led the agency since 2005. Yin’s work as vice minister of health touched on a broad swath of pharmaceutical manufacturing regulation and food safety enforcement.

China’s New SFDA Chief Has Public Health Background, International Ties

Yin Li becomes director of China’s State FDA, taking the reins from Shao Mingli, who led the agency since 2005. Yin’s work as vice minister of health touched on a broad swath of pharmaceutical manufacturing regulation and food safety enforcement.

FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply

FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS102867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel